ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors

Feb 12, 2019

ADMA Biologics Submits Response and Provides Supplemental Information to FDA for BIVIGAM® Complete Response Letter

Jan 7, 2019

ADMA to Host Conference Call to Discuss Recent Regulatory Update on BIVIGAM® PAS Submissions

Dec 20, 2018

ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions

Dec 19, 2018

ADMA Biologics Provides Regulatory Update for BIVIGAM®

Dec 19, 2018

ADMA Biologics Reports Third Quarter 2018 Financial Results

Nov 8, 2018

ADMA Biologics Receives PDUFA Date for RI-002

Oct 17, 2018

ADMA Biologics Provides Regulatory Update for BIVIGAM®

Oct 11, 2018

ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center

Oct 3, 2018

ADMA Biologics Resubmits Biologics License Application for RI-002

Oct 1, 2018